Developing a comprehensive Cardio-Oncology Program at a Cancer Institute: the Moffitt Cancer Center experience

Main Article Content

Michael G. Fradley | mfradley@health.usf.edu
Allen C. Brown
Bernadette Shields
Federico Viganego
Rongras Damrongwatanasuk
Aarti A. Patel
Gregory Hartlage
Natalee Roper
Julie Jaunese
Larry Roy
Roohi Ismail-Khan

Abstract

Cardio-oncology is a multidisciplinary field focusing on the management and prevention of cardiovascular complications in cancer patients and survivors. While the initial focus of this specialty was on heart failure associated with anthracycline use, novel anticancer agents are increasingly utilized and are associated with many other cardiotoxicities including hypertension, arrhythmias and vascular disease. Since its inception, the field has developed at a rapid pace with the establishment of programs at many major academic institutions and community practices. Given the complexities of this patient population, it is important for providers to possess knowledge of not only cardiovascular disease but also cancer subtypes and their specific therapeutics. Developing a cardio- oncology program at a stand-alone cancer center can present unique opportunities and challenges when compared to those affiliated with other institutions including resource allocation, cardiovascular testing availability and provider education. In this review, we present our experiences establishing the cardio-oncology program at Moffitt Cancer Center and provide guidance to those individuals interested in developing a program at a similar independent cancer institution.

Downloads month by month

Downloads

Download data is not yet available.

Article Details

How to Cite
Fradley, M. G., Brown, A. C., Shields, B., Viganego, F., Damrongwatanasuk, R., Patel, A. A., Hartlage, G., Roper, N., Jaunese, J., Roy, L., & Ismail-Khan, R. (2017). Developing a comprehensive Cardio-Oncology Program at a Cancer Institute: the Moffitt Cancer Center experience. Oncology Reviews, 11(2). https://doi.org/https://doi.org/10.4081/oncol.2017.340